Program Overview

THE MASTER’S IN TRANSLATIONAL MEDICINE (MTM) PROGRAM PROVIDES OPPORTUNITIES FOR STUDENTS FROM DIVERSE ACADEMIC BACKGROUNDS TO GAIN EXPERTISE IN APPLYING TRANSLATIONAL SCIENCE AND ENGINEERING APPROACHES TO PRODUCE PRACTICAL SOLUTIONS AND IMPACT HUMAN HEALTH.

 

     “Translational Medicine” refers to the process of transforming –“translating”– basic science discoveries into practical medical technologies for use with patients. Such technologies include medical devices, and computer applications.

     Our commitment to the development of a Translational Medicine degree program is driven by the mounting demand for engineers, physicians, biomedical scientists, and other professionals who can successfully translate our abundant science and technology innovations into actual advances in patient health and healthcare. The National Institutes of Health has given translational medicine a high priority. Through the MTM program students will learn the skills to integrate the science, technology, and business expertise required to drive scientific discoveries into public use for the improvement of health.

     The MTM program will engage collaborating faculty from across the campus, specifically the Grove School of Engineering and the Sophie Davis School of Biomedical Education/CUNY School of Medicine, and will be administered from the Grove School of Engineering. Collaborating external partners in the New York Center for Biomedical Engineering (NYCBE) and from regional health-related technology companies will also be recruited.

IMG_4876

    The central approach to our MTM program is the integration of engineering, clinical exposure, research, and entrepreneurship training  in a central yearlong interdisciplinary design-project experiential learning experience – the BioDesign Capstone project.

_MG_5171

 The BioDesign Capstone project will be mentored by well-established faculty members and external advisors and synthesizes the technical, clinical, economic, and regulatory issues involved in design and market implementation of medical product commercialization that are introduced in the didactic coursework.

We have specifically tailored the current curriculum to fit within three core areas to be integrated alongside the 3-semester BioDesign project:

  • Biomedical and Clinical sciences and Engineering (core and elective) courses designed to prepare students to identify disease targets and understanding how to apply biomedical engineering principals and technologies to create solutions; and
  • Clinical Evaluation courses focused on understanding testing of products in a clinical trial setting; and
  • Business Principles and Entrepreneurship courses that will give students the ability to consider legal, economic, organizational, regulatory, clinical, and technical issues associated with translating knowledge or technology into real-world use.

Thus, trainees will be uniquely positioned to successfully pursue those projects in industry, start-up or medical environments, and thus increase the rate at which bench research impacts patient care.